openPR Logo
Press release

Implantable Defibrillators Market 2024-2033: Growth Trends, Forecast & Competitive Landscape

04-26-2024 01:49 PM CET | Health & Medicine

Press release from: The Business research company

Implantable Defibrillators Market 2024-2033: Growth Trends,

The implantable defibrillators market size has grown steadily in recent years. It will grow from $5.46 billion in 2023 to $5.69 billion in 2024 at a compound annual growth rate (CAGR) of 4.2%. The growth in the historic period can be attributed to increased prevalence of cardiac disorders, clinical evidence and research, rise in aging population, increased awareness and education, collaborations and partnerships.

The implantable defibrillators market size is expected to see steady growth in the next few years. It will grow to $6.82 billion in 2028 at a compound annual growth rate (CAGR) of 4.6%. The growth in the forecast period can be attributed to remote monitoring and telemedicine integration, expansion of indications, focus on heart failure management, personalized medicine approaches, global expansion of healthcare infrastructure. Major trends in the forecast period include miniaturization and design innovations, remote monitoring and connectivity, personalized therapy approaches, leadless implantable defibrillators, battery technology advancements.

Market Overview -
An implantable defibrillator refers to a small, battery-operated device inserted into the chest to help regulate abnormal heart rhythms. It continuously monitors the heart's rhythm, and if it detects a dangerous or irregular rhythm, it delivers an electrical shock to the heart to restore a normal rhythm.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=10140&type=smp

Rising Prevalence Of Sudden Cardiac Arrest Fuels Growth In Implantable Defibrillators Market
The increase in the prevalence of sudden cardiac arrest is expected to boost the growth of the implantable defibrillators market. Sudden cardiac arrest (SCA) refers to a condition where the heart stops beating unexpectedly. Implantable defibrillators can provide lifesaving therapy by detecting and correcting abnormal heart rhythms that can lead to SCA. For instance, according to a report published by the Journal of the American College of Cardiology, a US-based medical journal, SCD causes 185,000 to 450,000 deaths annually in the US population or 7% to 18% of all fatalities. Therefore, the increase in the prevalence of sudden cardiac arrest is driving the growth of the implantable defibrillators market.

Competitive Landscape -
Major companies operating in the implantable defibrillators market report are Boston Scientific Corporation, LivaNova PLC, Biotronik SE & Co KG, MicroPort Scientific Corporation, Mayo Clinic, Medtronic plc, St. Jude Medical Inc., Abbott Laboratories, Sorin Group Italia S.r.l., Nihon Kohden Corporation, Koninklijke Philips N.V., Fukuda Denshi Co Ltd., Stryker Corporation, Progetti S.r.l., Imricor Medical Systems Inc., MRI Interventions Inc., ZOLL Medical Corporation, Physio-Control International Inc., Cardiac Science Corporation, Defibtech LLC, HeartSine Technologies LLC, Welch Allyn Inc., Schiller AG, CU Medical Systems Inc., Mindray Medical International Limited, Shenzhen Mindray Bio-Medical Electronics Co Ltd., Beijing M&B Electronic Instruments Co Ltd., Bexen Cardio SL, Pacemaker Technologies, Reva Medical Inc., Cardiac Insight Technologies, EBR Systems Inc., BioSensis Pty Ltd

Product Innovations In Implantable Defibrillators Market
Product innovations is the key trend gaining popularity in the implantable defibrillators market. Major companies operating in the implantable defibrillators market are focusing on developing new products to sustain in the market. For instance, in December 2023, Medtronic, an Ireland-based medical device company, launched its new type of implantable cardioverter-defibrillator. The Aurora extravascular ICD is a device that is inserted under the skin under the left armpit rather than under the collarbone. It is similar in size, shape, and battery life to the company's traditional transvenous ICDs, but it can provide defibrillation to patients undergoing cardiac arrest as well as ongoing pacemaker therapies. Its Epsila leads are then minimally invasively linked to the heart beneath the breastbone. The implant also has Medtronic's Smart Sense technology, which attempts to lower the risk of unwarranted shocks, and SureScan technology, which permits a patient to have an MRI while the device is placed.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/implantable-defibrillators-global-market-report

Key Segments -
The implantable defibrillators market covered in this report is segmented -
1) By Product Type: Single Chambered Implantable Defibrillators, Dual Chambered Implantable Defibrillators, Biventricular Implantable Defibrillators
2) By Procedure Type: Trans-Venous Implantable Defibrillators, Subcutaneous Implantable Defibrillators
3) By End User: Hospitals And Clinics, Ambulatory Surgery Centers, Other End Users

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Implantable Defibrillators Market 2024-2033: Growth Trends, Forecast & Competitive Landscape here

News-ID: 3477773 • Views:

More Releases from The Business research company

Shale Gas Market Report 2024 - Market Size, Growth Rate, Major Drivers And Key Trends | Royal Shell PLC, Exxon Mobil Corporation, PetroChina Company Limited, ConocoPhillips Company
Shale Gas Market Report 2024 - Market Size, Growth Rate, Major Drivers And Key T …
"The shale gas market size has grown rapidly in recent years. It will grow from $77.04 billion in 2023 to $88.27 billion in 2024 at a compound annual growth rate (CAGR) of 14.6%. The growth in the historic period can be attributed to energy security concerns, economic benefits, policy and regulatory support, global energy demand. The shale gas market size is expected to see rapid growth in the next
Rolling Stock Market Competitive And Growth Analysis 2024 | Alstom Holdings SA, Bombardier Inc., Construcciones y Auxiliar de Ferrocarriles SA
Rolling Stock Market Competitive And Growth Analysis 2024 | Alstom Holdings SA, …
"The rolling stock market size has grown strongly in recent years. It will grow from $58.65 billion in 2023 to $62.67 billion in 2024 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to increased demand for mass transportation, increased demand for intermodal transportation, development of rail transportation system, need for efficient and reliable transportation. The rolling stock market size
Digital Signal Processors Market Size, Trends And Report To 2024-2033
Digital Signal Processors Market Size, Trends And Report To 2024-2033
The digital signal processors market size has grown strongly in recent years. It will grow from $14.62 billion in 2023 to $15.97 billion in 2024 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to significant developments in wireless infrastructure, growing demand for digital signal processing within automotive applications drives its market growth, growing demand from thriving automotive industry
Compression Stockings Market Size, Analysis, Overview, Outlook By 2024-2033
Compression Stockings Market Size, Analysis, Overview, Outlook By 2024-2033
The compression stockings market size has grown strongly in recent years. It will grow from $1.65 billion in 2023 to $1.75 billion in 2024 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to prevalence of chronic diseases, advancements in material and design, regulatory support, medical advancements. The compression stockings market size is expected to see strong growth in the

All 5 Releases


More Releases for Implantable

Nanotechnology in Medical Devices Market 2028 by Implantable Materials, Active I …
The Insight Partners analysts forecasts the latest report on “Global Nanotechnology in Medical Devices Market (Covid-19) Impact and Analysis by 2028”, according to report; The Nanotechnology in Medical Devices Market report covers the overall and all-inclusive analysis of Market with all its factors that have an impact on market growth. This report is anchored on the thorough qualitative and quantitative assessment of the Nanotechnology in Medical Devices Market. The study
Nanomedical Devices Market Highest CAGR of 10.29% by 2023 | By Types Implantable …
The Global Nano Medical Devices Market is expected to grow at a CAGR of 10.29% during Forecasted Period 2017-2023. Nanomedical Devices Market - Segmentation The global Nanomedical Devices Market has been segmented on the basis of applications, end users, types, and lastly region. As per application-based segmentation, this market has been segmented into disease treatment & diagnosis, drug release regulation and other. Disease treatment & diagnosis has been sub-segmented into cancer, cardiovascular
Nanomedical Devices Market Highest CAGR of 10.29% by 2023 | By Types Implantable …
Nanomedical Devices Market - Segmentation The global nanomedical devices market has been segmented on the basis of applications, end users, types, and lastly region. As per application-based segmentation, this market has been segmented into disease treatment & diagnosis, drug release regulation and other. Disease treatment & diagnosis has been sub-segmented into cancer, cardiovascular diseases neurological diseases, and other. With regards to end users, the market has been segmented into clinics, hospitals,
Active Implantable Medical Devices Market (Implantable Cardioverter Defibrillato …
Global Active Implantable Medical Devices Market 2018 report includes Active Implantable Medical Devices Market Size, Revenue, market Share, Active Implantable Medical Devices industry volume, market Trends, Active Implantable Medical Devices Growth aspects. A wide range of applications, Utilization ratio, Supply and demand analysis are also consist in the report. It shows manufacturing capacity, Active Implantable Medical Devices Price during the Forecast period from 2018 to 2025. For In depth Information Get
Active Implantable Medical Devices Market by Product Type (Pacemaker, Implantabl …
The Global Active Implantable Medical Devices Market by product type (pacemaker, implantable cardioverter defibrillator, cardiac resynchronization therapy devices, neurostimulator, drug infusion pump, implantable loop recorder, cochlear implant, and others), and region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) was valued at US$ 16,721.2 million in 2016 and is projected to exhibit a CAGR of 5.4% over the forecast period (2017–2025), as highlighted in a new
Implantable Cardioverter Defibrillators Contribute Largest Revenue to the Global …
According to the study, the global active implantable medical devices market is likely to grow from $17.0 billion in 2016 to $28.9 billion by 2023. Technological advancements, increasing prevalence of cardiovascular diseases, rising healthcare expenditures and increasing research and development activities have been driving the growth of the global active implantable medical devices market. The market is further expected to gain revenue due to increasing geriatric population and incidence of